Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by MCA2009on Aug 30, 2010 5:46pm
298 Views
Post# 17397238

RE: RE: RE: THE IMPRESSION THAT I GET

RE: RE: RE: THE IMPRESSION THAT I GETI only say FDA because that is where SCT is shooting for approval.  I am with you though If i was the pipeline dude i would drag Alan to Japan and stand in the room with him while he sold this treatment.  I am hoping the industrial guys will break some ball$, but i am also freaked out that Alan needs to keep reminding people that they intend to continue as a biotech company.  It strikes me as something you say when that isn't your intention at all

MCA
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse